This training will focus on how QIAGEN Omicsoft Studio and Ingenuity Pathway Analysis (IPA) can be used discover new biomarkers, validate (or study) drug targets and identify novel mechanism of action with user and/or public checkpoint inhibitor datasets from resources like GEO, SRA, TCGA and more.
Attendees will learn how to
· Investigate expression of a gene/biomarker/drug target across different treatments and diseases
· Derive a biomarker/gene signature from specific condition (example non-responders of a drug, a specific disease/disease subtype and more)
· Correlate expression of multiple genes and biomarkers
· Compare different experimental groups (user and/or public data) at both gene expression and pathways/regulatory networks activity levels
Click here to register.